№ files_lp_3_process_7_070249
File format: docx
Character count: 3687
File size: 14 KB
This document provides information on the recommended dosage and potential side effects of the medication Duexis, intended for patients suffering from osteoarthritis or rheumatoid arthritis.
Year:
2023
Region / city:
N/A
Topic:
Medication dosage and side effects
Document type:
Medication information sheet
Organization / institution:
N/A
Author:
N/A
Target audience:
Patients prescribed Duexis
Effective period:
N/A
Approval date:
N/A
Date of changes:
N/A
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Topic:
Veterinary pharmacology
Type of document:
Reference text
Subject:
Antiemetic drugs and vomiting control
Scope:
Small animal medicine
Drugs included:
Phenothiazines, anticholinergics, antihistamines, metoclopramide, serotonin subtype 3 antagonists, butorphanol, maropitant
Indications:
Chemotherapy-induced emesis, radiation-induced emesis, motion sickness, vestibular vomiting, delayed gastric emptying, reflux gastritis, viral enteritis
Administration routes:
IV, IM, SC, PO
Adverse effects:
Hypotension, sedation, extrapyramidal signs, QT prolongation, ECG changes, CNS excitement, drooling, diarrhea
Pharmacologic targets:
Dopamine D2 receptors, serotonin subtype 3 receptors, NK-1 receptors, cholinergic and histaminic pathways
Species referenced:
Dogs and cats
Year:
2005-2015
Region:
The Netherlands
Topic:
Pediatric psychopharmacology
Document type:
Research article
Institution:
Erasmus Medical Centre, University of Groningen
Authors:
Sanne M. Kloosterboer, Catharina C.M. Schuiling-Veninga, Jens H.J. Bos, Luuk J. Kalverdijk, Birgit C.P. Koch, Gwen C. Dieleman, Manon H.J. Hillegers, Bram Dierckx
Funding:
The Netherlands Organisation for Health Research and Development (ZonMW), grant 836041011
Target audience:
Healthcare professionals, researchers
Data source:
IADB.nl community pharmacy prescription database
Study population:
Youths aged 0-19 years
Outcome measures:
Prevalence, incidence, dosages, duration of antipsychotic use, prior psychotropic medication
Key findings:
Stabilization of usage rates, decrease in dosages and duration, one in eight youths used antipsychotics ≥4 years, boys had longer median usage than girls
Type of source:
Peer-reviewed scientific article
Year:
2026
Region / City:
N/A
Topic:
Consultant Contract DBE Information
Document Type:
Form
Institution / Organization:
Caltrans
Author:
N/A
Target Audience:
Consultants, Local Agencies, Caltrans
Effective Period:
N/A
Approval Date:
N/A
Amendment Date:
N/A
Year:
2022
Region / City:
West Side, Township
Theme:
Stormwater management, infrastructure upgrade
Document Type:
Project proposal
Organization / Institution:
Neglia Engineering Associates
Author:
Township of West Side
Target Audience:
Local government officials, engineering professionals
Period of Validity:
Until completion of the project
Approval Date:
Nov 2022
Modification Date:
N/A
Year:
2026
Region / City:
N/A
Topic:
Consultant Contract, DBE Information
Document Type:
Form
Agency / Institution:
Caltrans
Author:
N/A
Target Audience:
Consultants, Local Agencies, Caltrans Representatives
Period of Validity:
N/A
Approval Date:
N/A
Amendment Date:
N/A
Year:
2021
Region / City:
Welwyn Garden City
Theme:
Estate Management, Architecture
Document Type:
Planning Application Decision
Organization:
Welwyn Hatfield Borough Council
Author:
Mr James Homer
Target Audience:
Residents, Property Owners, Local Authorities
Effective Period:
2021
Approval Date:
13 July 2021
Modification Date:
13 July 2021
Year:
2021
Region / City:
Welwyn Garden City
Subject:
Planning application for residential extensions
Document Type:
Planning application
Authority / Institution:
Welwyn Hatfield Borough Council
Author:
Mr James Homer
Target Audience:
Residents of Welwyn Garden City, property developers, architects
Period of Action:
Until 4 May 2024
Approval Date:
05 May 2021
Modification Date:
None
Year:
2024
Region / city:
USA
Topic:
Medical, Oncology
Document Type:
Educational Materials
Organization:
NCI CIRB
Author:
NCI
Target Audience:
Research staff, IRB members, clinical trial participants
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2023
Region / City:
United States
Topic:
Medicine, Side Effects, Clinical Trials
Document Type:
Educational Material
Organization:
NCI CIRB
Author:
N/A
Target Audience:
Research Staff, Clinical Trial Staff
Period of Validity:
N/A
Approval Date:
N/A
Modification Date:
N/A
Year:
2024
Region / city:
USA
Topic:
Medical Information, Cancer Treatment
Document Type:
Educational Resource
Author:
National Cancer Institute (NCI)
Target Audience:
Research staff, Clinical trial participants, Healthcare professionals
Action Period:
Ongoing
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2022
Region / City:
US
Topic:
Medical, Pharmacology
Document Type:
Research Resource
Organization / Institution:
National Cancer Institute (NCI)
Author:
Not specified
Target Audience:
Research staff, clinical trial personnel
Period of validity:
Not specified
Approval Date:
Not specified
Date of changes:
Not specified
Year:
2024
Region / city:
USA
Theme:
Medical / Oncology
Document type:
Side Effect Table
Organization:
NCI CIRB
Target Audience:
Research staff, Clinical trial participants
Period of validity:
N/A
Approval date:
N/A
Modification date:
N/A
Year:
2023
Region / City:
United States
Topic:
Side effects of chemotherapy
Document type:
Educational Material
Organization / Institution:
National Cancer Institute (NCI)
Author:
Not specified
Target audience:
Research staff, clinical trial participants
Effective period:
Not specified
Approval date:
Not specified
Date of revisions:
Not specified
Year:
2025
Region / city:
United States
Topic:
Side effects of cancer therapy
Document type:
Patient Educational Material
Author:
National Cancer Institute
Target audience:
Research staff, clinical trial participants
Period of validity:
N/A
Approval date:
N/A
Date of amendments:
N/A
Year:
2025
Region / city:
US
Theme:
Cancer Treatment, Side Effects
Document Type:
Medical Resource
Organization:
National Cancer Institute (NCI)
Author:
Not specified
Target Audience:
Research Staff, Medical Professionals
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
November 13, 2025